Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd. News

Fudan Zhangjiang (688505): High competition barriers for core products of leading international companies in photodynamic technology

長城國瑞證券Nov 25, 2020 00:00

Fudan Zhangjiang (688505) IPO Report: Photodynamic and Nanopharmaceutical Leaders Can Be Expected to Develop in the Future

興業證券Jun 22, 2020 00:00

Zhang Jiang, Fudan (688505): the purchase Strategy of Science and Technology Innovation Board's New shares

申萬宏源研究Jun 3, 2020 00:00

Fudan Zhangjiang (688505): inquiry Strategy of Science and Technology Board

國泰君安Jun 2, 2020 00:00

Fudan Zhangjiang (1349.HK): an innovative pharmaceutical company characterized by photodynamic drugs

西南證券Mar 10, 2019 00:00

Fudan Zhangjiang (01349.HK) Annual report comments: the growth rate of core varieties slows down and the listing of new products becomes a new increment.

興業證券Mar 17, 2017 00:00

Fudan Zhangjiang (1349.HK) research report: outstanding R & D capabilities of new products are expected to drive accelerated growth

興業證券Dec 14, 2016 00:00

Fudan Zhangjiang (1349.HK) comments: the R & D-based business model brings a premium for shares

銀河國際Jan 6, 2016 00:00

Deutsche Bank reassesses the purchase of Fudan Zhangjiang (01349.HK), and the target price rises to HK$10.7

德意志銀行Jun 1, 2015 15:46

Fudan Zhangjiang (1349.HK) Research brief: the product has obvious advantages in technological innovation.

國元(香港)May 16, 2014 00:00

复旦张江(1349.HK)调研纪要

國元(香港)Dec 18, 2013 00:00

复旦张江(08231.HK)：潜心研发 或成长为未来中国的“安进”

國泰君安國際Oct 10, 2013 00:00

Fudan Zhangjiang (08231.HK) Investment Value Analysis Report: Innovative Biomedical Enterprises Transforming to Industrialization

中信證券國際Nov 26, 2012 00:00